PROGNOS HEALTH INC.
NEW YORK, NY

Prognos Health Inc., headquartered at 85 Broad St, 16th Floor, New York City, NY, is a pioneering health technology company founded in May 2017 by Dr. Sundeep Bhan and Jason Bhan. Originally named Medivo Inc., which was sold to WebMD in its previous incarnation, Prognos Health aims to revolutionize healthcare through the integration of artificial intelligence (AI) and advanced analytics to track and predict diseases at their earliest stages. Established with a mission to improve global health outcomes, the company has been instrumental in leveraging vast clinical data sets to inform clinical decision-making more accurately and timely. Prognos employs over 80 professionals from diverse countries, cultures, and professional backgrounds, including engineers, data scientists, and clinicians. This multiculturally rich workforce is unified by a shared conviction to enhance healthcare efficacy through data integration. The company's innovative approach entails the application of descriptive and predictive analytics on clinical diagnostic data, enabling its clients to make more informed decisions. Situated originally in Florida but having transitioned operational activities predominantly between New York City (NY) and Delaware (DE), Prognos Health Inc. filed under the Florida Companies database with the filing number F17000002132 as a Foreign Profit Corporation (FORP). Notable corporate milestones include its name change, amended on December 5, 2017, from Medivo Inc. to Prognos Health Inc., with ongoing annual reporting commitments, including recent submissions such as that dated April 25, 2024. Under the leadership of President Dr. Sundeep Bhan and Vice President of Products Jason Bhan, along with Director Clarence So, Prognos continues its commitment to using cutting-edge technology to drive improvements in patient health outcomes globally.